BiotechTube
Home/Atara Biotherapeutics/Yanina Grant-Huerta
YG

Yanina Grant-Huerta

Chief Accounting Officer

Atara Biotherapeutics

Therapeutic Areas

OncologyAutoimmune DiseasesViral Diseases

Atara Biotherapeutics Pipeline

DrugIndicationPhase
EBVALLO (tabelecleucel)EBV+ Post-Transplant Lymphoproliferative Disease (PTLD)Approved (EU)
ATA3219B-cell Non-Hodgkin LymphomaPhase 1
ATA3271Advanced Mesothelioma & NSCLC (PD-L1+)Preclinical
Autoimmune ProgramUndisclosed Autoimmune Disease(s)Discovery

Leadership Team at Atara Biotherapeutics

CN
Cokey Nguyen, Ph.D.
President and Chief Executive Officer
View full Atara Biotherapeutics profile